Jafron Biomedical Co Ltd

300529 • SHE

¥16.37+¥0.04 (0.24%)

Estimate

P/E

22.1

EPS

0.74

Beta

0.438

Growth

Revenue, YoY

2.33%

Net income, YoY

16.81%

FCF, YoY

-1.51%

Forecast

P/E (FWD)

18.4

EPS (FWD)

0.89

Dividends

Dividend yield

3.18%

Annual payout

¥0.52

Next ex. div date

June 1, 27

Payout

113.69%

Div.growth, 5y

11.05%

Div.rating

About the company

Ticker

300529

ISIN

CNE100002995

Country

China

Sector (GICS)

Healthcare

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Frequently asked questions

What sector does Jafron Biomedical Co Ltd (300529) operate in?

Jafron Biomedical Co Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Jafron Biomedical Co Ltd (300529) current stock price?

As of the latest data, Jafron Biomedical Co Ltd stock price is CN¥16.37, with a previous close of CN¥16.33. Jafron Biomedical Co Ltd gained CN¥0.04 in the last trading session, representing a 0.24% increase.

What is Jafron Biomedical Co Ltd (300529) current market capitalization?

Jafron Biomedical Co Ltd market cap is approximately 13.07 billion.

What is Jafron Biomedical Co Ltd (300529) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.74, and the forward EPS is CN¥0.89.

What is Jafron Biomedical Co Ltd (300529) Price-to-Earnings (P/E) ratio?

Jafron Biomedical Co Ltd current P/E ratio is 22.12, with a forward P/E of 18.39.

Does Jafron Biomedical Co Ltd (300529) pay dividends?

Yes. Jafron Biomedical Co Ltd pays annual dividends with an annualized yield of 3.18% and an estimated annual payout of CN¥0.52 per share.

When is the next ex-dividend date for Jafron Biomedical Co Ltd (300529)?

The next ex-dividend date is scheduled for June 01, 2027.

What is Jafron Biomedical Co Ltd (300529) beta (volatility) score?

Jafron Biomedical Co Ltd has a beta of 0.438, indicating lower volatility than the overall market.